Titan Pharmaceuticals
TTNP
#10414
Rank
$6.13 M
Marketcap
$4.61
Share price
-3.76%
Change (1 day)
22.93%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -$2.81 Million USD

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$4.71 Million USD, an increase over its 2023 earnings that were of -$5.57 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$2.81 Million-40.4%
2024 -$4.71 Million-15.5%
2023 -$5.57 Million-45.43%
2022 -$10.21 Million16.29%
2021 -$8.78 Million-907.36%
2020 $1.08 M-106.6%
2019 -$16.46 Million82.4%
2018 -$9.03 Million-36.93%
2017 -$14.31 Million-378.62%
2016 $5.13 M-145.53%
2015 -$11.28 Million369.37%
2014 -$2.41 Million-125.9%
2013 $9.27 M-177.74%
2012 -$11.94 Million13.59%
2011 -$10.51 Million74.37%
2010 -$6.03 Million3.61%
2009 -$5.82 Million
2007 -$18.44 Million12.08%
2006 -$16.45 Million-28.65%
2005 -$23.06 Million-10.03%
2004 -$25.63 Million-6.08%
2003 -$27.28 Million-14.76%
2002 -$32.01 Million32.52%
2001 -$24.15 Million27.55%
2000 -$18.94 Million62.5%
1999 -$11.66 Million4.04%
1998 -$11.2 Million49.33%
1997 -$7.5 Million-27.88%
1996 -$10.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-$0.13 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-$11.81 Million 320.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.26 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
$26.14 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA